Project
A single-arm phase II trial of the addition of niraparib to anti-PD-L1 antibody maintenance in patients with SLFN11-positive, extensive-disease small cell lung cancer.
Ongoing - recruitment active · 2023 until 2027
Quinter Janine, Radovanovic Suzana, Jörger Markus
No results found.